Manufacturer of generic version of abortion pill mifepristone sues FDA to keep drug on the market
CBSN
Washington — The pharmaceutical company that makes the generic version of the widely used abortion pill mifepristone filed a lawsuit against the Food and Drug Administration on Wednesday in an effort to keep the drug on the market.
The dispute brought by GenBioPro in federal district court in Maryland comes amid looming uncertainty about the availability of mifepristone after a federal district court in Texas suspended the FDA's approval of the drug earlier this month, and an appeals court rolled back actions taken by the agency beginning in 2016.
Among the moves blocked by the U.S. Court of Appeals for the 5th Circuit was the FDA's 2019 approval of a GenBioPro's application to market a generic version of mifepristone. The Supreme Court issued a temporary order last week preserving access to the drug until 11:59 p.m. Wednesday, and the hold was extended to 11:59 p.m. Friday.
